Latest: FDA Approves New Biosimilar for Oncology Treatment

Eyebot Raises $20M to Scale 90-Second Vision Test and Doctor-Verified Prescriptions

0 Mins
What You Should Know: – Eyebot, the company behind the 90-second vision test kiosk that delivers doctor-verified glasses prescriptions, today announced it has raised $20 million in Series A funding. The round was led by General Catalyst, with participation from returning investors AlleyCorp, Baukunst, Village Global, and Ubiquity Ventures. – Eyebot is redefining how people access vision care by eliminating traditional barriers ... Read More
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago